MPO and glioblastoma: Specifically, they identified a unique subpopulation of myeloperoxidase (MPO)-positive neutrophil-like macrophages, which was related to reduced interactions with endothelial cells, enhanced cytotoxic functions and survival benefit for patients with GBM (73).